Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers

Nature Genetics

Volumn 43, Issue 8, 2011, Pages 797-800

  Miki, Daiki ^a,b   Ochi, Hidenori ^a,b   Hayes, C Nelson ^a,b   Abe, Hiromi ^a,b   Yoshima, Tadahiko ^a,c   Aikata, Hiroshi ^b   Ikeda, Kenji ^d   Kumada, Hiromitsu ^d   Toyota, Joji ^e   Morizono, Takashi ^a   Tsunoda, Tatsuhiko ^a   Kubo, Michiaki ^a   Nakamura, Yusuke ^f   Kamatani, Naoyuki ^a   Chayama, Kazuaki ^a,b  

^a RIKEN   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^d TORANOMON HOSPITAL   (Japan)

^e Sapporo Kosei General Hospital   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHROMOSOME 22; CHRONIC HEPATITIS; CONTROLLED STUDY; DEPDC5 GENE; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; JAPANESE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE COUNT; VIRUS CARRIER;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CARRIER STATE; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 22; DISEASE PROGRESSION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

HEPATITIS C VIRUS;

EID: 79960909219     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.876     Document Type: Article

References (31)

1. Yang, J.D. & Roberts, L.R. Hepatocellular carcinoma: a global view. Nat. Rev. Gastroenterol. Hepatol. 7, 448-458 (2010).
2. Barrera, J.M. et al. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C. Hepatology 21, 639-644 (1995).
3. Welzel, T.M. et al. Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 49, 1847-1858 (2009).
4. Yoshida, H. et al. Interferon therapy reduces the risk for hepatocellular carcinoma. Ann. Intern. Med. 131, 174-181 (1999).
5. Kiyosawa, K. et al. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology 127, S17-S26 (2004). (Pubitemid 39423366)
6. Taura, N. et al. Aging of patients with hepatitis C virus-associated hepatocellular carcinoma: long-term trends in Japan. Oncol. Rep. 16, 837-843 (2006).
7. Miki, D. et al. Clinicopathological features of elderly patients with hepatitis C virus-related hepatocellular carcinoma. J. Gastroenterol. 43, 550-557 (2008).
8. Takata, A. et al. HCC develops even in the early stage of chronic liver disease in elderly patients with HCV infection. Int. J. Mol. Med. 26, 249-256 (2010).
9. Yuen, M.F., Hou, J.L. & Chutaputti, A. Hepatocellular carcinoma in the Asia pacific region. J. Gastroenterol. Hepatol. 24, 346-353 (2009).
10. Manns, M.P. et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358, 958-965 (2001). (Pubitemid 32913521)
11. Zhang, H. et al. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat. Genet. 42, 755-758 (2010).
12. Ura, S. et al. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 49, 1098-1112 (2009).
13. Pe'er, I., Yelensky, R., Altshuler, D. & Daly, M.J. Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet. Epidemiol. 32, 381-385 (2008).
14. Yamauchi, T. et al. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat. Genet. 42, 864-868 (2010).
15. Ono, E. et al. Platelet count reflects stage of chronic hepatitis C. Hepatol. Res. 15, 192-200 (1999). (Pubitemid 29372020)
16. Poynard, T. & Bedossa, P. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. J. Viral Hepat. 4, 199-208 (1997). (Pubitemid 127733511)
17. Forns, X. et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36, 986-992 (2002).
18. Wai, C.T. et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38, 518-526 (2003).
19. Pohl, A. et al. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am. J. Gastroenterol. 96, 3142-3146 (2001). (Pubitemid 33095354)
20. Seng, T.J. et al. Complex chromosome 22 rearrangements in astrocytic tumors identified using microsatellite and chromosome 22 tile path array analysis. Genes Chromosom. Cancer 43, 181-193 (2005).
21. Kharrat, A. et al. Conformational stability studies of the pleckstrin DEP domain: definition of the domain boundaries. Biochim. Biophys. Acta 1385, 157-164 (1998). (Pubitemid 28277054)
22. Harada, Y. et al. Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells. Cancer Res. 70, 5829-5839 (2010).
23. Kanehira, M. et al. Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis. Oncogene 26, 6448-6455 (2007). (Pubitemid 47494219)
24. The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of Japan 3rd English edn. (Kanehara & Co., Ltd., Tokyo, Japan, 2010).
25. Yamaguchi-Kabata, Y. et al. Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am. J. Hum. Genet. 83, 445-456 (2008).
26. Ohnishi, Y. et al. A high throughput SNP typing system for genome-wide association studies. J. Hum. Genet. 46, 471-477 (2001). (Pubitemid 32744120)
27. Nam, J.M. A simple approximation for calculating sample sizes for detecting linear trend in proportions. Biometrics 43, 701-705 (1987).
28. Margolin, B.H. Test for trend in proportions. in Encyclopedia of statistical sciences. (eds. Klotz, S. & Johnson, N.L.) 334-336 (John Wiley & Sons, Inc., New York, New York, USA, 1988).
29. Menashe, I., Rosenberg, P.S. & Chen, B.E. PGA: Power calculator for case-control genetic association analyses. BMC Genet. 9, 36 (2008).
30. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007). (Pubitemid 47330214)
31. Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 (2005). (Pubitemid 40202029)